"As a member of the Oversight and Government Reform Committee, I have helped the main investigative arm of Congress review the effectiveness of federal laws and government programs. From oversight of Wall Street to holding federal regulators accountable, I will continue to work to ensure Vermonters’ tax dollars are being spent effectively and that federal agencies have proper oversight and transparency."
Spotlight on Oversight
More on Oversight
Rep. Peter Welch (D-Vt.) and Senator Ron Wyden (D-Ore.), joined by Rep. James Sensenbrenner (R-Wis.) and Senator Rand Paul (R-Ky.), have introduced legislation to force the president to disclose the topline annual budget request for each of the 16 federal agencies conducting intelligence activities. Currently, topline spending levels are classified and hidden from the taxpayer.
WASHINGTON - Rep. Peter Welch (D-Vt.) took to the House floor this morning to condemn yet another early morning tweetstorm by President Trump attacking Special Counsel Robert Mueller and undermining his independent investigation.
WASHINGTON - Rep. Peter Welch (D-Vt.) has joined Senator Elizabeth Warren (D-Mass.) in introducing legislation that would boost funding for critical medical research. The bill would pay for the new research by requiring large pharmaceutical companies that break the law and settle their cases to reinvest a percentage of their profits into medical research conducted by the National Institutes of Health (NIH) and Food and Drug Administration (FDA).
Rep. Peter Welch (D-Vt.) is not mincing words when it comes to Allergan Inc.’s deal with an American Indian tribe geared toward protecting one of the company’s top products.
“I was astonished at the creativity in craft manipulation to extend the patent,” Welch told MarketWatch on Thursday, adding, “they would only do that if they felt a kind of arrogant confidence that they can continue to get away with murder.”
Washington, DC—Today, Rep. Peter Welch (D-VT) joined House Oversight Committee Chairman Trey Gowdy (R-SC) and Rep. Elijah E. Cummings (D-MD) in sending a letter to the chief executive officer of Allergan demanding detailed information on the company’s unconventional transfer of its patents for the eye drug Restasis to the Saint Regis Mohawk tribe in order to maintain the company’s monopoly pricing power over the drug.
Washington, DC - Yesterday, the House of Representatives approved Rep. Peter Welch’s amendment to prohibit the Pentagon from using taxpayer dollars to purchase uniforms for Afghan National Army. The House vote follows a finding by the Special Inspector General for Afghanistan Reconstruction (SIGAR) that the Department of Defense wasted $28 million on licensing a camouflage pattern for Afghan army uniforms that replicates lush forests, even though most of Afghanistan is a desert.
Washington – Just days after the President proposed a $54 billion increase to defense spending, Congressman Kurt Schrader (OR-5) and Congressman Peter Welch (VT-AL) introduced the Department of Defense Overhead Cost Savings and Transparency Act which would declassify the entirety of a report from the Pentagon which revealed $125 billion in administrative waste.